Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

52.21
-4.0600-7.22%
Post-market: 51.50-0.7100-1.36%19:55 EDT
Volume:1.18M
Turnover:62.55M
Market Cap:1.55B
PE:-19.42
High:56.29
Open:56.27
Low:51.84
Close:56.27
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:21.23M
Volume Ratio:0.98
T/O Rate:5.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6887
EPS(LYR):-0.7339
ROE:-30.42%
ROA:-4.37%
PB:6.10
PE(LYR):-71.14

Loading ...

A Look At GeneDx Holdings (WGS) Valuation After Recent Share Price Volatility

Simply Wall St.
·
Jun 03

GeneDx to present at Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 27

13D Filings -- Barrons.com

Dow Jones
·
May 23

Major Insider Move Signals Growing Confidence in GeneDx Holdings

TIPRANKS
·
May 21

Casdin Capital acquires 500,000 GeneDx shares valued at $21,367,516.50

Reuters
·
May 21

A Look At GeneDx Holdings (WGS) Valuation After Q1 2026 Reset And Securities Investigation

Simply Wall St.
·
May 18

GeneDx director Keith Meister reports $13.75 million Class A common share purchase

Reuters
·
May 16

Corvex’s Keith Meister buys $48.44 million GeneDx common shares

Reuters
·
May 12

Stock Track | GeneDx Holdings Plummets 5.57% Intraday as Alphabet Dissolves Stake

Stock Track
·
May 08

Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom

Reuters
·
May 08

Why Is GeneDx Stock Surging Thursday?

Benzinga
·
May 08

GeneDx Holdings Corp : Piper Sandler Cuts Target Price to $50 From $130

THOMSON REUTERS
·
May 07

If AI Reshapes Healthcare, These Three Stocks Could Lead

Simply Wall St.
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

Stock Track | GeneDx Holdings Plummets 46.19% in Pre-Market on Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

GeneDx price target lowered to $85 from $153 at Craig-Hallum

TIPRANKS
·
May 05

Top Premarket Decliners

MT Newswires Live
·
May 05

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

GlobeNewswire
·
May 05

GeneDx Holdings Is Maintained at Buy by BTIG

Dow Jones
·
May 05

Piper Sandler Remains a Buy on GeneDx Holdings (WGS)

TIPRANKS
·
May 05